Hello Caroline - new research group leader at Labmed!
We are happy to introduce: Caroline Palm Apergi, new research group leader at Labmed and Clinical Research Center.
What research area are you involved in?
We are investigating novel therapies against childhood cancers. Currently we are focused on pediatric leukemia where we analyze the expression of specific cell cycle proteins and target them with oligonucleotides and small molecules. We also try to identify potential off targets that could be affected by the treatment.
What is the purpose and goal with your research?
Today the prognosis for resistant and relapsed patients are poor and many childhood cancer survivors suffer from both acute and late onset side effects such as infertility, cardiac toxicity and second primary cancers. Our hope is that we will contribute to developing more targeted therapies that are able to cure any type of pediatric leukemia diagnosis and that current side effects will be reduced.
Why did you decide to become a researcher?
When I was growing up, there was an animated show for children on how the body functions and what happens during an infection or an injury. It inspired me to study science and led me into the world of chemistry, molecular biology and later on experimental oncology.
In a perfect world, what is your dream to accomplish with your research?
Our dream is that future therapies will cure any type of childhood cancer and that the treatments will be free from side effects.
What do you like to do when you are not working at KI?
My children are still in preschool so when I am not at KI, I spend my time with my family doing sports, singing and playing the guitar.